It’s no secret that the biotech talent market is tightening. With near full employment across the industry, the Capital Region is feeling the same growing pains as they build out strategic initiatives in the wake of COVID-19.
Ed Radwinsky is a seasoned Human Resources professional with extensive experience in the biopharmaceutical and biotechnology industries. Radwinsky has a Bachelor’s in Psychology from the University of Maryland as well as a Master’s in Industrial and Organizational Psychology from the University of Tulsa. Additionally, he possesses a Senior Professional in Human Resources certification from the HR Certification Institute.
‘Candidate experience’ is a phrase that is frequently tossed around by talent acquisition leaders seeking to improve their recruiting and hiring practices. This makes sense, as the current job market is competitive, and wholly candidate driven: most desirable candidates are currently employed, often evaluating several job options in addition to ‘yours’. With that being said, the experience that you provide your candidates can be the difference between winning a new employee, or losing great talent to a competitor.
As some are now calling it, the greater Philadelphia region, or ‘Cellecon Valley, is garnering a lot of attention these days as a rapidly emerging Biopharma cluster, earning a defining spot among the top 10 clusters in the US.
Growing your business means aligning your executive team with your objectives. How do you know when new voices are needed? How do you recruit and retain the right voices?
Lonza Pharma and Biotech (Lonza) is one of the world’s leading contract development and manufacturing organizations with 37 sites across the U.S., Europe, Asia, and the Middle East.
The pandemic changed everything. We live differently, behave differently, and have come to appreciate the little things we might have taken for granted before COVID-19 took hold in the BioHealth Capital Region (BHCR).
In an incredibly short time, Gaithersburg, Maryland’s Novavax has advanced its SARS-CoV-2 vaccine candidate into Phase III trials and received FDA fast track designation, putting its vaccine very close to potential FDA approval. There has been a herculean effort underway by Novavax and other companies to deliver desperately needed pandemic protection to people across the globe.
Rockville, Maryland’s Advanced BioScience Laboratories, Inc. (ABL) is a rapidly growing, innovative, biotech company—a strategic viral GMP manufacturer and contract research organization with superb technical prowess. ABL is a CDMO and CRO providing GMP manufacturing and immunology solutions for gene therapies, oncolytics, vaccines, and other immunotherapeutics to biopharmaceutical, biotech, and life science organizations, and government agencies alike.
The biotech industry continues to grow rapidly across the nation, especially in the BHCR. The region’s strategy for hiring and retaining employees is a key driver of the BHCR’s steady, sustained growth.
